Can stem cells fight frailty? small safety trial shows promise
NCT ID NCT06063590
First seen Apr 17, 2026 · Last updated May 23, 2026 · Updated 2 times
Summary
This early-stage trial tested whether a single infusion of StromaForte, made from donor bone marrow cells, is safe for people with aging frailty. Twelve adults aged 60 to 85 who were mildly or moderately frail received the treatment. Researchers tracked side effects and changes in inflammation markers like TNF-alpha and CRP for six months to see if the therapy could help control frailty-related decline.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGING FRAILTY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Burjeel Medical City
Abu Dhabi, United Arab Emirates
Conditions
Explore the condition pages connected to this study.